McDavid Stilwell

Nessuna posizione attualmente

Patrimonio netto: 179 979 $ in data 31/03/2024

53 anni

Health Technology

Consumer Services

Profilo

McDavid Stilwell worked as a Director of Business Development & Communications at GTx, Inc. from 2005 to 2012.
He then worked as the SVP of Corporate Communications & Investor Relations at Sangamo Therapeutics, Inc. After that, he worked as the VP of Communications & Business Development at Orexigen Therapeutics, Inc. from 2012 to 2016.
Currently, he is the Chief Financial Officer at Coherus BioSciences, Inc. starting from 2021 and ending in 2023.
Mr. Stilwell completed his undergraduate degree from St. John's College in 1993 and earned an MBA from Harvard Business School in 2005.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
COHERUS BIOSCIENCES, INC. 0.07%	31/12/2023	75 305 ( 0.07% )	179 979 $	31/03/2024

Precedenti posizioni note di McDavid Stilwell

Società	Posizione	Fine
COHERUS BIOSCIENCES, INC.	Director of Finance/CFO	08/12/2023
OREXIGEN THERAPEUTICS, INC.	Investor Relations Contact	01/11/2016
GTx, Inc. GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN.	Public Communications Contact	01/01/2012
SANGAMO THERAPEUTICS, INC.	Investor Relations Contact	-

Vedi nel dettaglio l'esperienza di McDavid Stilwell

Formazione di McDavid Stilwell

Harvard Business School	Masters Business Admin
St. John's College	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di McDavid Stilwell

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
SANGAMO THERAPEUTICS, INC.	Health Technology
COHERUS BIOSCIENCES, INC.	Health Technology

Aziende private	2
GTx, Inc. GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN.	Health Technology
Orexigen Therapeutics, Inc. Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA.	Health Technology